☰

Kaladhar B. Reddy

Affiliations: 
Wayne State University, Detroit, MI, United States 
Area:
Cell Biology, Molecular Biology, Oncology
Google:
"Kaladhar Reddy"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Natasha Atanaskova grad student 2002 Wayne State
Joseph S. Krueger grad student 2002 Wayne State

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Venkatesh J, Rishi AK, Reddy KB. (2020) Novel strategies to target chemoresistant triple-negative breast cancer. Genes & Cancer. 11: 95-105
Yin S, Cheryan VT, Xu L, et al. (2017) Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. Plos One. 12: e0183578
Muthu M, Somagoni J, Cheriyan VT, et al. (2015) Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers. Journal of Biomedical Nanotechnology. 11: 1608-27
Ahmad A, Ginnebaugh KR, Yin S, et al. (2015) Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. Bmc Cancer. 15: 540
Yin S, Rishi AK, Reddy KB. (2015) Anti-estrogen‑resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment. Oncology Reports. 33: 1475-80
Yin S, Cheriyan VT, Rishi AK, et al. (2015) Abstract 2225: c-Myc and Frizzled 8 play a major role in the regulation of cancer stem cells and drug resistance in triple-negative breast cancer Cancer Research. 75: 2225-2225
Yin S, Xu L, Bonfil RD, et al. (2013) Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer. Molecular Cancer Therapeutics. 12: 491-8
Reddy KB, Yin S, Daniel RB, et al. (2013) Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer. Cancer Research. 73: 241-241
Wong C, Wang X, Smith D, et al. (2012) AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies. Breast Cancer Research and Treatment. 134: 671-81
Ahmad A, Reddy KB, Sarkar FH. (2012) Abstract A1: Functional significance of miR-10b in tamoxifen resistance of breast cancer cells Clinical Cancer Research. 18: A1-A1
See more...